Data / Form D filings / Cue Biopharma, Inc.
Cue Biopharma, Inc.: Form D filings
Cue Biopharma, Inc., a biotechnology company in Boston, MA, filed 7 Form D notices with the SEC between 2015 and 2026. The latest, on July 22, 2026, reports $50 million sold of a $50 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 40 GUEST STREET, Boston, MA, 02135
- Phone
- (617) 949-2680
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1645460
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | New notice | $49,999,927 | $49,999,927 | 4 | Jul 13, 2026 | sec.gov | |
| May 14, 2026 | New notice | $29,999,992 | $29,999,992 | 118 | May 4, 2026 | sec.gov | |
| Nov 21, 2022 | New notice | $29,999,993 | $29,999,993 | 64 | Nov 16, 2022 | sec.gov | |
| Dec 30, 2016 | Amendment | $16,414,900 | $16,414,900 | 133 | Dec 22, 2016 | sec.gov | |
| Dec 22, 2016 | New notice | $20,000,000 | $20,000,000 | 133 | Dec 22, 2016 | sec.gov | |
| Jun 19, 2015 | New notice | $1,000,000 | $0 | $1,000,000 | 1 | Jun 15, 2015 | sec.gov |
| Jun 19, 2015 | New notice | $10,000,000 | $10,000,000 | 121 | Jun 15, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Shao-Lee Lin | Executive Officer, Director | |
| Dominic Borie | Executive Officer | |
| Sumita Ray | Executive Officer | |
| Daniel Camardo | Director | |
| Pamela Garzone | Director | |
| Viola Meehan | Director | |
| Pasha Sarraf | Director | |
| Michael Meluzio | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 20, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cue Biopharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.